ITMR Itamar Medical Ltd ADR

Itamar Medical’s WatchPAT™300 Home Sleep Apnea Testing Device Receives Approval in Japan

Itamar Medical’s WatchPAT™300 Home Sleep Apnea Testing Device Receives Approval in Japan
EN
01/10/2020

Underlying

ITMRItamar Medical Ltd ADR

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Itamar Medical Ltd ADR

 PRESS RELEASE
Free
ITMR Itamar Medical ...

Itamar Medical Reports Third Quarter 2021 Financial Results

Itamar Medical Reports Third Quarter 2021 Financial Results - Revenues Increased 23% Year-over-Year to $13.6 Million - - U.S. WatchPAT™ Revenues Increased 27% Year-over-Year to $11.3 Million - CAESAREA, Israel, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today reported unaudited financial results for the third quarter of 2021. “Third quarter results represent the strong traction our WatchPAT™ platform technolo...

November 18, 2021 1 EN
 PRESS RELEASE
Free
ITMR Itamar Medical ...

Itamar Medical Appoints Marga Ortigas-Wedekind to its Board of Directo...

Itamar Medical Appoints Marga Ortigas-Wedekind to its Board of Directors CAESAREA, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Marga Ortigas-Wedekind to its Board of Directors. Ms. Ortigas-Wedekind brings more than 30 years of medical technology and digital health experience including leadership roles in commercial and strategic marketing. She is currently the Chief Commercial Strategy Of...

August 12, 2021 1 EN
 PRESS RELEASE
Free
ITMR Itamar Medical ...

Itamar Medical Reports Second Quarter 2021 Financial Results

Itamar Medical Reports Second Quarter 2021 Financial Results - Revenues Increased 41% Year-over-Year to $12.6 Million - - U.S. WatchPATTM Revenues Increased 53% Year-over-Year to $10.1 Million - - Raised Full Year 2021 Revenue Guidance to a Range of $53 Million to $54 Million - - Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT - CAESAREA, Israel, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pat...

August 10, 2021 1 EN
 PRESS RELEASE
Free
ITMR Itamar Medical ...

Itamar Medical to Report Second Quarter Financial Results and Host Con...

Itamar Medical to Report Second Quarter Financial Results and Host Conference Call on Tuesday, August 10, 2021 CAESAREA, Israel, July 28, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that it will report its financial results for the second quarter 2021 before the U.S. market opens on Tuesday, August 10, 2021. The Company will host a conference call that day at 8:00 a.m. Eastern Time, 3:00 p.m. Israel Time ...

July 28, 2021 1 EN
 PRESS RELEASE
Free
ITMR Itamar Medical ...

Itamar Medical to Present at the Ladenburg Thalmann Annual Healthcare ...

Itamar Medical to Present at the Ladenburg Thalmann Annual Healthcare Conference on Wednesday, July 14, 2021 CAESAREA, Israel, June 30, 2021 (GLOBE NEWSWIRE) -- ItamarTM Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the company will present at the upcoming Ladenburg Thalmann Annual Healthcare Conference. Itamar’s management is scheduled to present on Wednesday, July 14, 2021 at 8:30 a.m. ET/ 5:30 a.m. PT. Interested parties may access a...

June 30, 2021 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch